|
業務類別
|
Biotechnology |
|
業務概覽
|
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment. |
| 公司地址
| 3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216 |
| 電話號碼
| +1 844 427-8100 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.seastarmedical.com |
| 員工數量
| 17 |
| Mr. Michael Messinger, C.P.A. |
Chief Financial Officer |
-- |
29/04/2026 |
| Mr. Bradford K. Towne |
Controller and Principal Accounting Officer |
-- |
25/03/2026 |
| Mr. Eric Schlorff |
Director and Chief Executive Officer |
美元 406.50K |
29/04/2026 |
| Mr. Kevin Chung, M.D. |
Chief Medical Officer |
美元 345.00K |
29/04/2026 |
|
|
| Mr. Kenneth Van Heel |
Independent Director |
29/04/2026 |
| Mr. Eric Schlorff |
Director and Chief Executive Officer |
29/04/2026 |
| Ms. Jennifer A. Baird |
Chairman of the Board |
29/04/2026 |
| Ms. Bernadette N. Vincent |
Independent Director |
29/04/2026 |
| Mr. John Neuman |
Independent Director |
29/04/2026 |
|
|
|
|
